Xavier Matias-Guiu Guia
Grau: Doctor/a
973 705 340
fjmatiasguiu.lleida.ics(ELIMINAR)@gencat.cat
ResearcherID: http://www.researcherid.com/rid/C-3039-2009
Grups
Publicacions
-
Domingo, P; Matias-Guiu, X; Pujol, RM; Domingo, JC; Arroyo, JA; Sambeat, MA; Vazquez, G
Switching to nevirapine decreases insulin levels but does not improve subcutaneous adipocyte apoptosis in patients with highly active antiretroviral therapy-associated lipodystrophy
JOURNAL OF INFECTIOUS DISEASES 184 1197-1201. .
-
Gras, E; Pons, C; Machin, P; Matias-Guiu, X; Prat, J
Loss of heterozygosity at the RB-1 locus and pRB immunostaining in epithelial ovarian tumors: a molecular, immunohistochemical, and clinicopathologic study
INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY 20 335-340. .
-
Gras, E; Cortes, J; Diez, O; Alonso, C; Matias-Guiu, X; Baiget, M; Prat, J
Loss of heterozygosity on chromosome 13q12-q14, BRCa-2 mutations and lack of BRCa-2 promoter hypermethylation in sporadic epithelial ovarian tumors
CANCER 92 787-795. .
[doi:10.1002/1097-0142(20010815)92:4<787::AID-CNCR1384>3.0.CO;2-4]
-
Rocha, AS; Soares, P; Seruca, R; Maximo, V; Matias-Guiu, X; Cameselle-Teijeiro, J; Sobrinho-Simoes, M
Abnormalities of the E-cadherin/catenin adhesion complex in classical papillary thyroid carcinoma and in its diffuse sclerosing variant
JOURNAL OF PATHOLOGY 194 358-366. .
-
Matias-Guiu, X; Catasus, L; Bussaglia, E; Lagarda, H; Garcia, A; Pons, C; Munoz, J; Arguelles, R; Machin, P; Prat, J
Molecular pathology of endometrial hyperplasia and carcinoma
HUMAN PATHOLOGY 32 569-577. .
-
Palacios, J; Catasus, L; Moreno-Bueno, G; Matias-Guiu, X; Prat, J; Gamallo, C
beta- and gamma-catenin expression in endometrial carcinoma. Relationship with clinicopathological features and microsatellite instability
VIRCHOWS ARCHIV 438 464-469. .
-
Esteller, M; Cordon-Cardo, C; Corn, PG; Meltzer, SJ; Pohar, KS; Watkins, DN; Capella, G; Peinado, MA; Matias-Guiu, X; Prat, J; Baylin, SB; Herman, JG
p14(aRF) silencing by promoter hypermethylation mediates abnormal intracellular localization of MDM2
CANCER RESEARCH 61 2816-2821. .
-
Perez-Losada, E; Pujol, RM; Domingo, P; Matias-Guiu, X; Lenti, J; Lopez-Pousa, A; Alomar, A
Hypertrichosis lanuginosa acquisita preceding extraskeletal Ewing's sarcoma
CLINICAL AND EXPERIMENTAL DERMATOLOGY 26 182-183. .
-
Pujol, RM; Perez-Losada, E; Matias-Guiu, X; Fuentes, J; Alonso, C; Alomar, A; Craven-Bartle, J
Postirradiation multiple minute digitate porokeratosis
JOURNAL OF CUTANEOUS MEDICINE AND SURGERY 5 126-130. .
-
Lagarda, H; Catasus, L; Arguelles, R; Matias-Guiu, X; Prat, J
K-ras mutations in endometrial carcinomas with microsatellite instability
JOURNAL OF PATHOLOGY 193 193-199. .
[doi:10.1002/1096-9896(2000)9999:9999<::AID-PATH769>3.0.CO;2-9]
-
Canos, JC; Serrano, A; Matias-Guiu, X
Paucicellular variant of anaplastic thyroid carcinoma: Report of two cases
ENDOCRINE PATHOLOGY 12 157-161. .
-
Catasus, L; Matias-Guiu, X; Machin, P; Zannoni, GF; Scambia, G; Benedetti-Panici, P; Prat, J
Frameshift mutations at coding mononucleotide repeat microsatellites in endometrial carcinoma with microsatellite instability
CANCER 88 2290-2297. .
[doi:10.1002/(SICI)1097-0142(20000515)88:10<2290::AID-CNCR13>3.0.CO;2-I]
Projectes
- Unravelling the molecular and phenotypic complexity of endometriosis through new models and omics integration: towards a personalized clinical management
- Homologous recombination deficiency in high-grade endometrial cancers. Biomarkers and impact of intratumor heterogeneity.
- EPH Receptor Signaling in Endometrial Cancer
- Ajuts per a la contractació de personal investigador novell (FI)
- Personalized Immunotherapy for Endometrial Cancer; Acronym: ExCITE (Endometrial Cancer Immunotherapy)
- "Multi-Omics data for Cancer Research and the Development of New Diagnostics and Therapies"
- EFFICACY: Nuevas estrategias para incrementar efectividad de los tratamientos con ABTL0812
- Perfiles epigenéticos asociados a patrones de metastasis en cáncer de endometrio
- CONTRACTES D'INCORPORACIO DE CIENTIFICS I TECNOLEGS: INCORPORACIO D'UNA DOCTORA PER A L'ACCIO ANTITUMORAL DELS CANNABINOIDES EN EL CARCINOMA D'ENDOMETRI
- DISCOVERY, VALIDATION AND IMPLEMENTATION OF BIOMARKERS FOR PRECISION ONCOLOGY
- Desarrollo de nuevas aproximaciones en el manejo individualizado de pacientes con cancer ginecológico (PREDICTGYN)
- VALIDACION DE ANEXINA 2 COMO PREDICTOR DE RECIDIVA EN EL CANCER DE ENDOMETRIO. DISEÑO DE NUEVAS ESTRATEGIAS TERAPEUTICAS. ANXARECU